The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
Open accessAbstract
BACKGROUND: Interventions to reduce sexually transmitted infections (STIs) among men who have sex with men (MSM) are needed. METHODS: (chlamydia), or syphilis in the past year. Participants were randomly assigned in a 2:1 ratio to take 200 mg of doxycycline within 72 hours after condomless sex (doxycycline postexposure prophylaxis) or receive standard care without doxycycline. STI testing was performed quarterly. The primary end point was the incidence of at least one STI per follow-up quarter. RESULTS: Of 501 participants (327 in the PrEP cohort and 174 in the PLWH cohort), 67% were White, 7% Black, 11% Asian or Pacific Islander, and 30% Hispanic or Latino. In the PrEP cohort, an STI was diagnosed in 61 of 570 quarterly visits (10.7%) in the doxycycline group and 82 of 257 quarterly visits (31.9%) in the standard-care group, for an absolute difference of -21.2 percentage points and a relative risk of 0.34 (95% confidence interval [CI], 0.24 to 0.46; P<0.001). In the PLWH cohort, an STI was diagnosed in 36 of 305 quarterly visits (11.8%) in the doxycycline group and 39 of 128 quarterly visits (30.5%) in the standard-care group, for an absolute difference of -18.7 percentage points and a relative risk of 0.38 (95% CI, 0.24 to 0.60; P<0.001). The incidences of the three evaluated STIs were lower with doxycycline than with standard care; in the PrEP cohort, the relative risks were 0.45 (95% CI, 0.32 to 0.65) for gonorrhea, 0.12 (95% CI, 0.05 to 0.25) for chlamydia, and 0.13 (95% CI, 0.03 to 0.59) for syphilis, and in the PLWH cohort, the relative risks were 0.43 (95% CI, 0.26 to 0.71), 0.26 (95% CI, 0.12 to 0.57), and 0.23 (95% CI, 0.04 to 1.29), respectively. Five grade 3 adverse events and no serious adverse events were attributed to doxycycline. Of the participants with gonorrhea culture available, tetracycline-resistant gonorrhea occurred in 5 of 13 in the doxycycline groups and 2 of 16 in the standard-care groups. CONCLUSIONS: The combined incidence of gonorrhea, chlamydia, and syphilis was lower by two thirds with doxycycline postexposure prophylaxis than with standard care, a finding that supports its use among MSM with recent bacterial STIs. (Funded by the National Institutes of Health; DoxyPEP ClinicalTrials.gov number, NCT03980223.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Sexually transmitted disease surveillance
O'Connor, B. H., Tillett, H., Berrie, J. R. H., Emslie, J. A. N., & Adler, M. W. (1982) · BMJ · doi:10.1136/bmj.284.6318.825-d · Cited by 2,185
Humphries, R., Bobenchik, A. M., Hindler, J. A., & Schuetz, A. N. (2021) · Journal of Clinical Microbiology · doi:10.1128/jcm.00213-21 · Cited by 1,493
Wi, T., Lahra, M. M., Ndowa, F., Bala, M., Dillon, J.-A. R., Ramon-Pardo, P., Eremin, S. R., Bolan, G., & Unemo, M. (2017) · PLOS Medicine · doi:10.1371/journal.pmed.1002344 · Cited by 600
Molina, J.-M., Charreau, I., Chidiac, C., Pialoux, G., Cua, E., Delaugerre, C., Capitant, C., Rojas-Castro, D., Fonsart, J., Bercot, B., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30725-9 · Cited by 449
Bolan, R. K., Beymer, M. R., Weiss, R. E., Flynn, R. P., Leibowitz, A. A., & Klausner, J. D. (2015) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000000216 · Cited by 206
Ocular Syphilis — Eight Jurisdictions, United States, 2014–2015
Oliver, S. E., Aubin, M., Atwell, L., Matthias, J., Cope, A., Mobley, V., Goode, A., Minnerly, S., Stoltey, J., Bauer, H. M., et al. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6543a2 · Cited by 161
Methodologies and Cell Lines Used for Antimicrobial Susceptibility Testing of Chlamydia spp
Suchland, R. J., Geisler, W. M., & Stamm, W. E. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.636-642.2003 · Cited by 159
Kelley, C. F., Vaughan, A. S., Luisi, N., Sanchez, T., Salazar, L. F., Frew, P. M., Cooper, H. L. F., DiClemente, R. J., del Río, C., Sullivan, P. S., et al. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2015.0013 · Cited by 89
Barbee, L. A., & Cyr, S. B. S. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac043 · Cited by 83
Cited by
Gandhi, R. T., Landovitz, R. J., Sax, P. E., Smith, D. M., Springer, S. A., Günthard, H. F., Thompson, M. A., Bedimo, R. J., Benson, C. A., Buchbinder, S. P., et al. (2025) · JAMA · doi:10.1001/jama.2024.24543 · Cited by 265
Self-citation
Metadata
- Authors
- Luetkemeyer, A. F., Donnell, D., Dombrowski, J. C., Cohen, S., Grabow, C., Brown, C. E., Malinski, C., Perkins, R., Nasser, M., Lopez, C., Vittinghoff, E., Buchbinder, S. P., Scott, H., Charlebois, E. D., Havlir, D. V., Soge, O. O., & Celum, C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-04-06
- Volume
- 388
- Issue
- 14
- Pages
- 1296-1306
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4362640977
- Cited by
- 468
- References
- 18
- FWCI
- 87.72
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. https://app.cochat.ai/papers/10.1056/nejmoa2211934
- The paper
- Luetkemeyer, A. F., Donnell, D., Dombrowski, J. C., Cohen, S., Grabow, C., Brown, C. E., Malinski, C., Perkins, R., Nasser, M., Lopez, C., Vittinghoff, E., Buchbinder, S. P., Scott, H., Charlebois, E. D., Havlir, D. V., Soge, O. O., & Celum, C. (2023). Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2211934
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.